{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:56:57Z","timestamp":1792609017720,"version":"4.5.0"},"reference-count":30,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2023,6,16]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Blood eosinophil counts have been studied in patients with stable chronic obstructive pulmonary disease (COPD) and are a useful biomarker to guide inhaled corticosteroid use. Less is known about eosinophil counts during severe exacerbation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective study, 2645 patients admitted consecutively with COPD exacerbation across six UK hospitals were included in the study, and the clinical diagnosis was confirmed by a respiratory specialist. The relationship between admission eosinophil count, inpatient death and 1-year death was assessed. In a backward elimination, Poisson regression analysis using the log-link function with robust estimates, patients\u2019 markers of acute illness and stable-state characteristics were assessed in terms of their association with eosinopenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1369 of 2645 (52%) patients had eosinopenia at admission. Those with eosinopenia had a 2.5-fold increased risk of inpatient death compared with those without eosinopenia (12.1% vs 4.9%, RR=2.50, 95%\u2009CI 1.88 to 3.31, p&lt;0.001). The same mortality risk with eosinopenia was seen among the subgroup with pneumonic exacerbation (n=788, 21.3% vs 8.5%, RR=2.5, 95%\u2009CI 1.67 to 2.24, p&lt;0.001). In a regression analysis, eosinopenia was significantly associated with: older age and male sex; a higher pulse rate, temperature, neutrophil count, urea and C reactive protein level; a higher proportion of patients with chest X-ray consolidation and a reduced Glasgow Coma Score; and lower systolic and diastolic blood pressure measurements and lower oxygen saturation, albumin, platelet and previous admission counts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>During severe COPD exacerbation, eosinopenia is common and associated with inpatient death and several markers of acute illness. Clinicians should be cautious about using eosinophil results obtained during severe exacerbation to guide treatment decisions regarding inhaled corticosteroid use.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2022-219463","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T17:20:38Z","timestamp":1690219238000},"page":"1090-1096","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD"],"prefix":"10.1136","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6916-8862","authenticated-orcid":false,"given":"Carlos","family":"Echevarria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-4869","authenticated-orcid":false,"given":"Jennifer K","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0228-0854","authenticated-orcid":false,"given":"Stephen C","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"2024051320342208000_78.11.1090.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916046"},{"key":"2024051320342208000_78.11.1090.2","unstructured":"GOLD . Global initiative for chronic obstructive lung disease; 2022."},{"key":"2024051320342208000_78.11.1090.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037923","article-title":"DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2020","journal-title":"BMJ Open"},{"key":"2024051320342208000_78.11.1090.4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026047","article-title":"Association between the peripheral blood eosinophil counts and COVID-19: a meta-analysis","volume":"100","author":"Huang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"2024051320342208000_78.11.1090.5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12630-021-01920-8","article-title":"The role of eosinophils in sepsis and acute respiratory distress syndrome: a scoping review","volume":"68","author":"Al Duhailib","year":"2021","journal-title":"Can J Anaesth"},{"key":"2024051320342208000_78.11.1090.6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1164\/rccm.201912-2384PP","article-title":"Blood eosinophil counts in clinical trials for chronic obstructive pulmonary disease","volume":"202","author":"Singh","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051320342208000_78.11.1090.7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.chest.2019.12.043","article-title":"POINT: are eosinophils useful for the management of COPD? Yes","volume":"157","author":"Wade","year":"2020","journal-title":"Chest"},{"key":"2024051320342208000_78.11.1090.8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.202004-1013ED","article-title":"Blood eosinophil-directed management of airway disease: the past, present and future","volume":"202","author":"Pavord","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051320342208000_78.11.1090.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207775"},{"key":"2024051320342208000_78.11.1090.10","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211197"},{"key":"2024051320342208000_78.11.1090.11","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202103"},{"key":"2024051320342208000_78.11.1090.12","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2015.015"},{"key":"2024051320342208000_78.11.1090.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0235LE"},{"key":"2024051320342208000_78.11.1090.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30206-X"},{"key":"2024051320342208000_78.11.1090.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30188-5"},{"key":"2024051320342208000_78.11.1090.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2009.01651.x"},{"key":"2024051320342208000_78.11.1090.17","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2147\/COPD.S226783","article-title":"Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease","volume":"14","author":"Wu","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024051320342208000_78.11.1090.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201108-1553OC"},{"key":"2024051320342208000_78.11.1090.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00062614"},{"key":"2024051320342208000_78.11.1090.20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","article-title":"Eosinophils in COPD exacerbations are associated with increased readmissions","volume":"151","author":"Couillard","year":"2017","journal-title":"Chest"},{"key":"2024051320342208000_78.11.1090.21","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.2147\/COPD.S170743","article-title":"Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization","volume":"13","author":"B\u00e9langer","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024051320342208000_78.11.1090.22","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2020.1757274","article-title":"Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis","volume":"7","author":"Jabarkhil","year":"2020","journal-title":"Eur Clin Respir J"},{"key":"2024051320342208000_78.11.1090.23","first-page":"2550","article-title":"30 day mortality and Eosinopenia in patients with pneumonia","volume":"44","author":"Echevarria","year":"2014","journal-title":"Eur Respir J"},{"key":"2024051320342208000_78.11.1090.24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(19)30176-6","article-title":"Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial","volume":"7","author":"Sivapalan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024051320342208000_78.11.1090.25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108041"},{"key":"2024051320342208000_78.11.1090.26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109789"},{"key":"2024051320342208000_78.11.1090.27","doi-asserted-by":"crossref","DOI":"10.1186\/cc6883","article-title":"Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units","volume":"12","author":"Abidi","year":"2008","journal-title":"Crit Care"},{"key":"2024051320342208000_78.11.1090.28","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s10096-019-03583-2","article-title":"White blood cell count and Eosinopenia as valuable tools for the diagnosis of bacterial infections in the ED","volume":"38","author":"Lavoignet","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024051320342208000_78.11.1090.29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","article-title":"An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal","volume":"204","author":"Celli","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051320342208000_78.11.1090.30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/COPD.S287705","article-title":"Standardisation of clinical assessment, management and follow-up of acute hospitalised exacerbation of COPD: a Europe-wide consensus","volume":"16","author":"Ramakrishnan","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2022-219463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T03:50:44Z","timestamp":1715658644000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2022-219463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,10,17]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/thorax-2022-219463"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2022-219463","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]}}}